Listed

Nephros Inc: Form 10-Q for the period ended Sep 30, 2018

Filed with the SEC on Nov 8, 2018 and accepted by EDGAR at Nov 8, 2018, 16:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-07-01 to 2018-09-30$1.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2018-01-01 to 2018-09-30$4.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2018-07-01 to 2018-09-30$772.0kus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2018-01-01 to 2018-09-30$1.8mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2018-07-01 to 2018-09-30$952.0kus-gaap:GrossProfit
Gross profit9 months2018-01-01 to 2018-09-30$2.2mus-gaap:GrossProfit
Selling, general and administrative3 months2018-07-01 to 2018-09-30$1.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2018-01-01 to 2018-09-30$3.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2018-07-01 to 2018-09-30−$511.0kus-gaap:OperatingIncomeLoss
Operating income9 months2018-01-01 to 2018-09-30−$2.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2018-07-01 to 2018-09-30$32.0kus-gaap:InterestExpense
Interest expense9 months2018-01-01 to 2018-09-30$146.0kus-gaap:InterestExpense
Net income3 months2018-07-01 to 2018-09-30−$566.0kus-gaap:NetIncomeLoss
Net income9 months2018-01-01 to 2018-09-30−$2.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-07-01 to 2018-09-30−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2018-01-01 to 2018-09-30−$0.04us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2018-01-01 to 2018-09-30−$3.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2018-09-30$5.3mus-gaap:Cash
Current assetsAt period end2018-09-30$8.4mus-gaap:AssetsCurrent
Total assetsAt period end2018-09-30$9.4mus-gaap:Assets
Current liabilitiesAt period end2018-09-30$1.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-09-30$2.3mus-gaap:Liabilities
Long-term debtAt period end2018-09-30$1.1mus-gaap:LongTermDebt
Shareholders' equityAt period end2018-09-30$4.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-18-015466. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.